Design, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4.
about
Fascaplysin as a specific inhibitor for CDK4: insights from molecular modellingDesign, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agentsSynthesis of rigidified eIF4E/eIF4G inhibitor-1 (4EGI-1) mimetic and their in vitro characterization as inhibitors of protein-protein interactionRuthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies.Synthesis and molecular modeling of novel tetrahydro-β-carboline derivatives with phosphodiesterase 5 inhibitory and anticancer properties.The diketopiperazine-fused tetrahydro-β-carboline scaffold as a model peptidomimetic with an unusual α-turn secondary structure.
P2860
Design, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Design, synthesis and biologic ...... selective inhibitors of CDK4.
@ast
Design, synthesis and biologic ...... selective inhibitors of CDK4.
@en
type
label
Design, synthesis and biologic ...... selective inhibitors of CDK4.
@ast
Design, synthesis and biologic ...... selective inhibitors of CDK4.
@en
prefLabel
Design, synthesis and biologic ...... selective inhibitors of CDK4.
@ast
Design, synthesis and biologic ...... selective inhibitors of CDK4.
@en
P2093
P1476
Design, synthesis and biologic ...... d selective inhibitors of CDK4
@en
P2093
Bhabatosh Chaudhuri
Daniel Emmerson
Matthew R Smith
Paul R Jenkins
Robert G Britton
Sachin Mahale
Stephen J Gray
P304
P356
10.1016/J.BMC.2008.07.002
P407
P577
2008-07-08T00:00:00Z